恒瑞医药
(600276)
| 流通市值：3057.46亿 | | | 总市值：3181.21亿 |
| 流通股本：63.79亿 | | | 总股本：66.37亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 24,408,762,724.19 | 15,455,583,728.11 | 8,140,565,320.77 | 31,629,416,193.83 |
| 营业总成本 | 17,294,495,762.71 | 11,313,140,405.95 | 5,642,928,613.81 | 23,093,097,613.72 |
| 其他经营收益 | | | | |
| 营业利润 | 7,993,893,749.4 | 5,087,742,489.21 | 2,607,443,528 | 8,990,002,841.99 |
| 利润总额 | 7,728,629,944.88 | 4,952,417,467.84 | 2,556,862,055.54 | 8,707,625,538.18 |
| 净利润 | 6,923,154,058.06 | 4,465,282,419.88 | 2,280,994,705.34 | 7,717,002,245.78 |
| 每股收益 | | | | |
| 其他综合收益 | -48,149,058.09 | -31,800,666.03 | -13,182,740.49 | 10,995,435.22 |
| 综合收益总额 | 6,875,004,999.97 | 4,433,481,753.85 | 2,267,811,964.85 | 7,727,997,681 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 54,553,738,286.93 | 49,607,557,380.05 | 52,044,194,705.35 | 51,490,372,457.04 |
| 非流动资产: | | | | |
| 非流动资产合计 | 22,165,786,026.64 | 21,165,564,618.84 | 19,249,667,735.53 | 18,376,943,316.7 |
| 资产总计 | 76,719,524,313.57 | 70,773,121,998.89 | 71,293,862,440.88 | 69,867,315,773.74 |
| 流动负债: | | | | |
| 流动负债合计 | 6,897,123,405.09 | 4,247,215,561.44 | 5,636,723,710.95 | 6,369,237,286 |
| 非流动负债: | | | | |
| 非流动负债合计 | 2,485,092,849.9 | 1,536,166,020.39 | 1,510,052,451.98 | 1,701,255,073.49 |
| 负债合计 | 9,382,216,254.99 | 5,783,381,581.83 | 7,146,776,162.93 | 8,070,492,359.49 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 66,814,410,542.4 | 64,466,430,205.71 | 63,626,264,350.1 | 61,272,068,641.41 |
| 股东权益合计 | 67,337,308,058.58 | 64,989,740,417.06 | 64,147,086,277.95 | 61,796,823,414.25 |
| 负债和股东权益合计 | 76,719,524,313.57 | 70,773,121,998.89 | 71,293,862,440.88 | 69,867,315,773.74 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 26,302,070,463.12 | 14,357,158,249.68 | 6,924,351,344.85 | 34,834,159,889.58 |
| 经营活动现金流出小计 | 18,458,420,333.71 | 12,370,154,377.34 | 6,137,905,444.14 | 23,598,781,758.95 |
| 经营活动产生的现金流量净额 | 7,843,650,129.41 | 1,987,003,872.34 | 786,445,900.71 | 11,235,378,130.63 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 158,131,660.34 | 68,206,934.09 | 11,372,939.06 | 221,403,914.71 |
| 投资活动现金流出小计 | 2,985,916,430.06 | 1,892,805,322.86 | 735,118,964.87 | 2,961,906,284.58 |
| 投资活动产生的现金流量净额 | -2,827,784,769.72 | -1,824,598,388.77 | -723,746,025.81 | -2,740,502,369.87 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,844,676,131.05 | 1,491,095,462.51 | 299,534,222.25 | 12,265,679,059.4 |
| 筹资活动现金流出小计 | 3,281,222,700.46 | 3,080,882,038.32 | 485,251,178.59 | 4,483,971,687.7 |
| 筹资活动产生的现金流量净额 | -1,436,546,569.41 | -1,589,786,575.81 | -185,716,956.34 | 7,781,707,371.7 |
| 汇率变动对现金及现金等价物的影响 | -939,738,909.26 | -696,646,671.36 | -349,701,516.56 | -360,132,552.71 |
| 现金及现金等价物净增加额 | 2,639,579,881.02 | -2,124,027,763.6 | -472,718,598 | 15,916,450,579.75 |
| 期末现金及现金等价物余额 | 42,795,132,578.43 | 38,031,524,933.81 | 39,682,834,099.41 | 40,155,552,697.41 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -2,124,027,763.6 | - | 15,916,450,579.75 |
最新报告期：2026-11-06| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东方证券 | 伍云飞 | 1.40 | 1.59 | 1.80 | 2026-11-06 |
| 首创证券 | 王斌 | 1.32 | 1.50 | 1.86 | 2026-11-05 |
| 招商证券 | 梁广楷,焦玉鹏,许菲菲 | 1.38 | 1.57 | 1.92 | 2026-11-04 |
| 中信建投 | 沈毅,袁清慧,贺菊颖 | 1.36 | 1.46 | 1.72 | 2026-11-04 |
| 中邮证券 | 陈灿,盛丽华 | 1.28 | 1.47 | 1.73 | 2026-11-03 |